This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Van Besien, Koen
Item Type | Name |
Concept
|
Multiple Myeloma
|
Academic Article
|
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Academic Article
|
Controversies in multiple myeloma: to transplant or not?
|
Academic Article
|
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
|
Academic Article
|
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
|
Academic Article
|
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
|
Academic Article
|
Arterial thrombosis in four patients treated with thalidomide.
|
Academic Article
|
Lenalidomide after stem-cell transplantation for multiple myeloma.
|
Academic Article
|
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
|
Academic Article
|
Reduced-intensity and nonmyeloablative conditioning regimens.
|
Academic Article
|
Statement of Retraction: Huang H, Wu D, Fu J, Chen G. "multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid".
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
|
Academic Article
|
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
|
Academic Article
|
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.
|
Academic Article
|
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
|
Academic Article
|
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
|
Academic Article
|
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
|
Academic Article
|
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
|